Insider · CIK 0001398764

Chiniara Ellen

Reports to the SEC for 4 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001398764

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+90K sh	—	—	90,000
2025-03-03	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+55K sh	—	—	55,000
2025-03-03	KYMRKymera Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+27.5K sh	—	—	82,326
2025-03-03	KYMRKymera Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−1,833 sh	$30.33	−$55.6K	80,493
2025-03-03	KYMRKymera Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−408 sh	$31.00	−$12.6K	80,085
2025-02-11	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2025-01-06	KYMRKymera Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−3,129 sh	$41.75	−$131K	54,826
2024-03-01	KYMRKymera Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+21.8K sh	—	—	55,960
2024-03-01	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+131K sh	—	—	130,531
2024-02-09	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-01-04	KYMRKymera Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−3,295 sh	$22.58	−$74.4K	34,205
2023-02-08	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-01-03	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+225K sh	—	—	225,000
2023-01-03	KYMRKymera Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+37.5K sh	—	—	37,500
2022-04-26	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2021-07-21	ALEXION PHARMACEUTICALS, INC.D Disposition to Issuer	EVP & Chief Legal Officer	DDisposition to Issuer	−117K sh	—	—	0
2021-07-14	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+27.7K sh	—	—	116,850
2021-07-14	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+26.8K sh	—	—	89,193
2021-02-28	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+19.3K sh	—	—	62,381
2020-12-16	ALEXION PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Legal Officer	FTax Payment	−2,988 sh	$157.96	−$472K	43,004
2020-12-16	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+38K sh	—	—	62,917
2020-12-16	ALEXION PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Legal Officer	FTax Payment	−16.9K sh	$157.96	−$2.67M	45,992
2020-12-15	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+56 sh	$95.53	+$5,349.68	43,060
2020-03-02	ALEXION PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Legal Officer	FTax Payment	−1,263 sh	$90.54	−$114K	24,898
2020-02-28	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+10.2K sh	—	—	26,161
2019-12-15	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+54 sh	$93.86	+$5,068.44	24,952
2019-02-28	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+8,250 sh	—	—	15,961
2019-02-28	ALEXION PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Legal Officer	FTax Payment	−633 sh	$132.92	−$84.1K	7,711
2018-02-28	ALEXION PHARMACEUTICALS, INC.A Award	EVP & Chief Legal Officer	AAward	+8,344 sh	—	—	8,344
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−11.8K sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−975 sh	—	—	0
2017-10-03	ALERE INC.D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−32.8K sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−5,250 sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−35K sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−10K sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−5,000 sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−8,331 sh	—	—	0
2017-10-03	ALERE INC.Restricted Stock UnitsD Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−19.5K sh	—	—	0
2017-10-03	ALERE INC.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC, Chief Ethics Officer&Sec	DDisposition to Issuer	−1,500 sh	—	—	0
2017-08-31	ALERE INC.M Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	+6,667 sh	—	—	34,927
2017-08-31	ALERE INC.F Tax Payment	GC, Chief Ethics Officer&Sec	FTax Payment	−2,163 sh	$49.46	−$107K	32,764
2017-08-31	ALERE INC.Restricted Stock UnitsM Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	−6,667 sh	—	—	0
2017-02-16	ALERE INC.F Tax Payment	GC, Chief Ethics Officer&Sec	FTax Payment	−2,432 sh	$40.40	−$98.3K	28,260
2017-02-16	ALERE INC.Restricted Stock UnitsM Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	−7,236 sh	—	—	14,470
2017-02-16	ALERE INC.Restricted Stock UnitsM Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	−2,500 sh	—	—	5,000
2017-02-16	ALERE INC.M Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	+2,500 sh	—	—	24,267
2017-02-16	ALERE INC.M Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	+7,236 sh	—	—	30,692
2017-02-16	ALERE INC.F Tax Payment	GC, Chief Ethics Officer&Sec	FTax Payment	−811 sh	$40.40	−$32.8K	23,456
2016-11-30	ALERE INC.J Other	GC, Chief Ethics Officer&Sec	JOther	+238 sh	$33.73	+$8,027.264	21,767
2016-10-14	ALERE INC.M Exercise/Conversion	GC, Chief Ethics Officer&Sec	MExercise/Conversion	+7,096 sh	$37.74	+$268K	26,016

Recent filings

Accepted (ET)
Jan 54
Chiniara Ellen0001171843-26-000057
SEC(opens sec.gov)
Mar 34
Chiniara Ellen0000950170-25-031148
SEC(opens sec.gov)
Feb 134
Chiniara Ellen0001171843-25-000826
SEC(opens sec.gov)
Jan 64
Chiniara Ellen0000950170-25-002266
SEC(opens sec.gov)
Mar 44
Chiniara Ellen0000950170-24-025093
SEC(opens sec.gov)
Feb 144
Chiniara Ellen0001171843-24-000793
SEC(opens sec.gov)
Jan 54
Chiniara Ellen0000950170-24-002536
SEC(opens sec.gov)
Feb 94
Chiniara Ellen0001171843-23-000855
SEC(opens sec.gov)
Jan 44
Chiniara Ellen0000899243-23-000630
SEC(opens sec.gov)
Apr 284
Chiniara Ellen0001171843-22-002945
SEC(opens sec.gov)
Jul 234
Chiniara Ellen0000899866-21-000068
SEC(opens sec.gov)
Jul 164
Chiniara Ellen0000899866-21-000053
SEC(opens sec.gov)
Mar 24
Chiniara Ellen0000899866-21-000027
SEC(opens sec.gov)
Dec 184
Chiniara Ellen0000899866-20-000091
SEC(opens sec.gov)

Companies

Address

51 SAWYER ROAD, SUITE 200

WALTHAM, MA, 02453